Nuveen Asset Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,103,840 shares of LXRX stock, worth $916,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,103,840

Previous 216,266 410.41%

Holding current value

$916,187

Previous $363,000 377.41%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.39 $1.34 Million - $2.12 Million	887,574 Added 410.41%	1,103,840 $1.73 Million
Q2 2024 Aug 09, 2024	SELL	$1.54 - $2.28 $474,182 - $702,037	-307,911 Reduced 58.74%	216,266 $363,000
Q1 2024 May 13, 2024	BUY	$1.3 - $3.58 $147,070 - $405,008	113,131 Added 27.52%	524,177 $1.26 Million
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.53 $1,867 - $2,856	1,867 Added 0.46%	411,046 $628,000
Q3 2023 Nov 14, 2023	BUY	$1.06 - $2.33 $95,384 - $209,665	89,985 Added 28.19%	409,179 $446,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $253,012 - $410,703	117,680 Added 58.4%	319,194 $730,000
Q1 2023 May 15, 2023	SELL	$1.99 - $2.68 $85,840 - $115,604	-43,136 Reduced 17.63%	201,514 $489,000
Q4 2022 Feb 14, 2023	SELL	$1.8 - $2.56 $111,358 - $158,376	-61,866 Reduced 20.18%	244,650 $467,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $109,769 - $194,076	56,582 Added 22.64%	306,516 $736,000
Q2 2022 Aug 15, 2022	BUY	$1.31 - $2.69 $7,930 - $16,285	6,054 Added 2.48%	249,934 $465,000
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $2,977 - $5,940	1,527 Added 0.63%	243,880 $530,000
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $1.3 Million - $2.1 Million	-340,947 Reduced 58.45%	242,353 $904,000
Q3 2021 Nov 12, 2021	SELL	$3.38 - $5.35 $287,918 - $455,729	-85,183 Reduced 12.74%	583,300 $2.83 Million
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $916,518 - $1.31 Million	222,456 Added 49.88%	668,483 $3.07 Million
Q1 2021 May 17, 2021	BUY	$3.45 - $9.09 $806,361 - $2.12 Million	233,728 Added 110.09%	446,027 $2.62 Million
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $11,985 - $41,893	11,415 Added 5.68%	212,299 $726,000
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.3 $53,142 - $69,844	30,367 Added 17.81%	200,884 $401,000
Q1 2020 May 14, 2020	BUY	$1.8 - $4.28 $21,403 - $50,893	11,891 Added 7.5%	170,517 $332,000
Q4 2019 Feb 14, 2020	SELL	$3.16 - $5.15 $47,655 - $77,667	-15,081 Reduced 8.68%	158,626 $658,000
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $10,195 - $56,583	-8,496 Reduced 4.66%	173,707 $522,000
Q2 2019 Aug 15, 2019	BUY	$5.35 - $7.11 $974,786 - $1.3 Million	182,203 New	182,203 $1.15 Million

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History